Which Parkinson’s Symptoms Respond Best to DBS?
DBS does not affect every Parkinson’s symptom equally
Deep brain stimulation, or DBS, is a surgical treatment used to control selected symptoms of Parkinson’s disease. It does not cure Parkinson’s disease or stop the condition from progressing.
The aim is to reduce troublesome motor symptoms and help patients spend more of the day in a functional and predictable state. The expected benefit depends on the symptom being treated, the patient’s response to medication, the selected brain target and accurate postoperative programming.
Which symptoms usually respond best?
Tremor
Tremor is often one of the symptoms that responds most strongly to DBS. This can include tremor that improves with Parkinson’s medication as well as severe tremor that remains troublesome despite appropriate medication.
For some patients, disabling medication-resistant tremor may therefore support consideration of DBS even when other motor symptoms remain reasonably controlled.
Rigidity
Rigidity—the stiffness or resistance felt when moving an arm or leg—usually responds well to DBS, particularly when it has previously improved with levodopa.
Reducing rigidity may make everyday movements more comfortable and can help with dressing, turning and walking.
Bradykinesia
Bradykinesia means slowness of movement. Patients may notice difficulty initiating a movement, taking shorter steps or performing tasks such as buttoning a shirt.
DBS can improve bradykinesia, especially when the symptom responds to levodopa. The amount of benefit differs between individuals and may be less predictable when slowness is related to balance, cognition or advanced axial symptoms.
Motor fluctuations
As Parkinson’s disease progresses, medication may work well for part of the day but wear off before the next dose. Patients can alternate between relatively mobile “on” periods and difficult “off” periods.
DBS can reduce the duration and severity of these off periods, allowing more consistent motor control during the day.
Dyskinesias
Dyskinesias are involuntary, often twisting or flowing movements associated with Parkinson’s medication. DBS can reduce dyskinesias either through a direct stimulation effect or by allowing medication adjustments, depending on the selected target and the individual treatment plan.
Why is the levodopa response important?
One of the most useful principles in DBS assessment is:
Motor symptoms that improve with levodopa are generally more likely to improve with DBS.
This is why a formal levodopa challenge is often included in the preoperative assessment. The patient is examined during an off-medication state and again after taking medication.
However, levodopa response is not the only consideration. Medication-resistant tremor may still respond well to DBS, and the overall decision also depends on cognitive health, mood, general medical condition and the patient’s goals.
In my discussions with patients, I emphasise that DBS candidacy is determined by the complete clinical picture—not by a single symptom, scan or test result.
You can read more about the assessment process in Who Is a Suitable Candidate for DBS Surgery?.
Which symptoms are less predictable?
DBS is generally less reliable for symptoms that do not improve with medication, particularly:
Balance problems and recurrent falls
Freezing of gait that persists during a good medication “on” period
Speech difficulties
Swallowing problems
Cognitive impairment
Autonomic symptoms, such as urinary or blood-pressure problems
Some gait or freezing symptoms may improve if they are levodopa-responsive. However, speech, balance and gait can also worsen as Parkinson’s disease progresses, even when tremor and other motor symptoms remain well controlled by stimulation.
DBS should therefore not be presented as a treatment for every Parkinson’s-related difficulty.
Does the DBS target make a difference?
The two most frequently used targets in Parkinson’s disease are the subthalamic nucleus (STN) and the globus pallidus internus (GPi). Both can improve the main motor symptoms in appropriately selected patients.
The choice may be influenced by several factors, including:
The need to reduce medication
The severity of dyskinesias
Cognitive or mood considerations
Age and general medical condition
The patient’s most disabling symptoms
There is no single target that is automatically best for every patient. Target selection should be individualised by an experienced multidisciplinary team.
What should a patient realistically expect?
A useful goal is not simply to ask, “Will DBS work?” but:
Which specific symptoms are we expecting DBS to improve, and how would that change daily life?
For one patient, success may mean fewer hours of severe tremor. For another, it may mean shorter off periods, less dyskinesia or greater independence with everyday activities.
Clear expectations before surgery are essential because DBS can improve selected symptoms substantially while leaving others unchanged.
Frequently asked questions
Does DBS help Parkinson’s tremor?
It often does. Tremor is among the symptoms that may respond particularly well, including selected cases of tremor that respond inadequately to medication.
Can DBS improve walking?
DBS may improve walking difficulties that also improve with levodopa. Medication-resistant freezing, balance loss and falls are less predictable and may not improve.
Does DBS improve speech?
Speech response is variable. DBS is not primarily performed to improve speech, and speech may remain unchanged or occasionally worsen depending on disease-related and stimulation-related factors.
Can DBS prevent Parkinson’s disease from progressing?
No. DBS is a symptomatic treatment. It can provide meaningful motor control but does not stop the underlying progression of Parkinson’s disease.
Conclusion
DBS provides its most consistent benefits for tremor, rigidity, bradykinesia, motor fluctuations and dyskinesias. Symptoms that respond to levodopa are generally the most likely to respond to stimulation, with medication-resistant tremor being an important exception.
The best results begin with careful patient selection, realistic goals and a clear understanding of which symptoms DBS is—and is not—expected to improve.
Kaan Tugberk Ozdemir, MDNeurosurgeon – Izmir, Türkiye
This article is intended for general information and does not replace an individual medical assessment, diagnosis or treatment recommendation.
References
Comments